January 3, 2017 / 1:00 AM / 7 months ago

BRIEF-Actinogen Medical receives FDA approval to commence alzheimer's disease clinical trial

1 Min Read

Jan 3 (Reuters) - Actinogen Medical Ltd

* FDA approval to commence alzheimer's disease clinical trial

* Expects to receive similar approvals from regulatory authorities in Australia and UK within next two months Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below